Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard (Q58622618)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 1, 2011

Language	Label	Description	Also known as
English	Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard	scientific article published on September 1, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard (English)

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

Thierry Poynard

object named as

Thierry Poynard

1

0 references

author name string

Victor de Ledinghen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Jean Pierre Zarski

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Carol Stanciu

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Mona Munteanu

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Julien Vergniol

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Julie France

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Anca Trifan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Gilles Le Naour

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Jean Christophe Vaillant

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Vlad Ratziu

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Frederic Charlotte

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Fibrosis-TAGS group

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21889468

11 December 2024

publication date

1 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0168827811006635?httpAccept=text/xml

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

https://api.elsevier.com/content/article/PII:S0168827811006635?httpAccept=text/plain

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Journal of Hepatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

56

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

541-548

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Evaluation of diagnostic tests when there is no gold standard. A review of methods.

1

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Non-invasive assessment of liver fibrosis: are we ready?

2

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy

3

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

4

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Performance of transient elastography for the staging of liver fibrosis: a meta-analysis

5

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?

6

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

8

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations

9

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: The ANRS HCEP-23 study

10

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Liver stiffness measurements in patients with HBV vs HCV chronic hepatitis: A comparative study

11

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

12

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Features associated with success rate and performance of fibroscan measurements for the diagnosis of cirrhosis in HCV patients: A prospective study of 935 patients

14

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome

15

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

16

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Random effects models in latent class analysis for evaluating accuracy of diagnostic tests.

17

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited

21

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Exceeding the limits of liver histology markers

23

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Sources of variability in histological scoring of chronic viral hepatitis

24

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

25

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

26

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases

27

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies

28

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure

29

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

30

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program

31

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

32

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.

33

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

34

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

35

1 reference

10.1016/J.JHEP.2011.08.007

https://api.crossref.org/works/10.1016/J.JHEP.2011.08.007

11 December 2024

Identifiers

10.1016/J.JHEP.2011.08.007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21889468 AND SRC:MED&resulttype=core&format=json

12 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q58622618&oldid=2286009121"